Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 21 August 2009, doi:10.1136/bmj.b3173
Cite this as: BMJ 2009;339:b3173
Timothy R Betts, consultant cardiologist and electrophysiologist
1 Department of Cardiology, John Radcliffe Hospital, Oxford OX3 9DU
EP.doctors@orh.nhs.uk
Timothy Betts argues that focusing on rate will cause less harm to patients, but Andrew Mitchell (doi:10.1136/bmj.b3174) believes that achieving sinus rhythm will have better long term results
| The first 150 words of the full text of this article appear below. |
Both sides of the debate on whether to control rhythm or rate agree that sinus rhythm is better than atrial fibrillation.1 If a strategy to control rhythm could guarantee to be efficacious, cost effective, and have no risk of adverse events, there would be no argument. Unfortunately, this is rarely the case. Rhythm control is difficult to achieve and initially requires the use of potentially toxic drugs. If the objective is to "first do no harm," rate control is more important.
Six randomised controlled trials comparing rate and rhythm control have clearly shown that mortality (whether as a primary or composite end point) is not reduced with rhythm control.2 3 4 5 6 7 In the two largest of these there was even a trend to increased mortality in the rhythm control group.3 4 This is probably because of the potential toxicity of rhythm control drugs and the inappropriate withdrawal of warfarin in the rhythm control
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?